Skip to content

Visual Quality Following Aspheric Intraocular Lens (IOL) Implantation - a Comparative Clinical Study

Visual Quality Following Aspheric and Monovision Lens Implantation - a Comparative Clinical Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01544777
Acronym
751
Enrollment
42
Registered
2012-03-06
Start date
2012-02-29
Completion date
2012-08-31
Last updated
2015-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphakia, Cataract

Keywords

Aphakia, Cataract

Brief summary

To evaluate visual acuity and quality of vision in participants undergoing cataract surgery with a Hoya model 751 intra-ocular lens and to compare the visual results to the common monofocal lens in use.

Interventions

DEVICEStudy IOL

Aspheric IOL for correction of aphakia

DEVICEHoya iSert 751

Model 751 in one eye, standard IOL in other eye

DEVICENegatively aspheric IOL

Negatively aspheric IOL in both eyes

Sponsors

Hoya Surgical Optics, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Senile cataract * Patient identified as a candidate for cataract surgery and IOL implantation * Willing to sign informed consent document approved by the Ethical Committee * Willing to complete all required tests and exams per this protocol

Exclusion criteria

* Amblyopia * History or evidence of any ocular disease that may affect visual acuity * Previous ocular surgery, including refraction surgery * Ocular anomalies (e.g. microphthalmos, kerataconous) * Subjects with greater than 1.0 D of corneal astigmatism * Subjects who experience intraoperative complications that could affect postoperative IOL centration or tilt

Design outcomes

Primary

MeasureTime frame
Uncorrected Visual Acuity (UCVA) (ETDRS)for distance, intermediate and nearUp to 3 months

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026